Ferrous gluconate 300mg tablets

Pays: Royaume-Uni

Langue: anglais

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ingrédients actifs:

Ferrous gluconate

Disponible depuis:

Crescent Pharma Ltd

Code ATC:

B03AA03

DCI (Dénomination commune internationale):

Ferrous gluconate

Dosage:

300mg

forme pharmaceutique:

Oral tablet

Mode d'administration:

Oral

classe:

No Controlled Drug Status

Type d'ordonnance:

Valid as a prescribable product

Descriptif du produit:

BNF: 09010101; GTIN: 5017123041136

Notice patient

Product:
Ferrous Gluconate 300mg (Surepharm)
Item Code:
P1251T
Size:
148 x 297 mm
Min. Point size:
8.5pt
O. Artwork:
10/12/19
Proof No.
3
Amendment Date
08/01/20
Process Black
Keyline - Does not print
Colours Used
PATIENT INFORMATION LEAFLET
FERROUS GLUCONATE
Ferrous Gluconate
300mg
Tablets
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
• KEEP THIS LEAFLET. YOU MAY NEED TO READ IT AGAIN.
• IF YOU HAVE ANY FURTHER QUESTIONS, ASK YOUR DOCTOR, OR PHARMACIST
OR NURSE.
• THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU ONLY. DO NOT PASS IT ON
TO OTHERS. IT MAY HARM THEM,
EVEN IF THEIR SIGNS OF ILLNESS ARE THE SAME AS YOURS.
• IF YOU GET ANY SIDE EFFECTS, TALK TO YOUR DOCTOR, OR PHARMACIST OR
NURSE. THIS INCLUDES ANY
POSSIBLE SIDE EFFECTS NOT LISTED IN THIS LEAFLET. SEE SECTION 4.
What is in this leaflet:
1.
What Ferrous Gluconate Tablets are and what they are used for
2.
What you need to know before you take Gluconate Tablets
3.
How to take Ferrous Gluconate Tablets
4.
Possible side effects
5.
How to store Ferrous Gluconate Tablets
6.
Contents of the pack and other information
1. What Ferrous Gluconate Tablets are and what they are used for
Ferrous Gluconate 300mg Tablets are used for the treatment and
prevention of iron deficiency.
Ferrous Gluconate is a form of iron. Iron is necessary for the
production of haemoglobin (protein
in red blood cells), which carries oxygen around the body. Iron is
involved in the formation of
myoglobin, a pigment that stores oxygen in muscles for use during
exercise.
Talk to your doctor or pharmacist before taking Ferrous Gluconate
300mg Tablets:
2. What you need to know before you take Ferrous Gluconate Tablets
Do not take Ferrous Gluconate Tablets if:
Warnings and precautions
Other medicines and Ferrous Gluconate Tablets
Ferrous Gluconate 300mg Tablets with food and drink
Pregnancy, breast-feeding and fertility
Driving and using machines
you are allergic to ferrous gluconate, medicines containing iron or
any

Résumé des caractéristiques du produit

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Ferrous Gluconate Tablets 300 mg.
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 300 mg Ferrous Gluconate.
Excipients with known effect: each tablet contains 2.659mg Sucrose,
0.346mg
Carmoisine Dioxide Lake, 1.22mg Ponceau 4R and 0.028mg of Sunset
Yellow
FCF Aluminium Lake.
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Red, sugar coated, deep convex tablets.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Ferrous
Gluconate
300mg
Tablets
are
indicated
for
the
prevention
and
treatment of iron deficiency states.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
Adults and the elderly:
Prophylactic: 2 tablets daily
Therapeutic: 4-6 tablets daily in divided doses
_Paediatric population: _
Children (aged 6-12 years):
Prophylactic: 1 or 2 tablets daily
Therapeutic: 3 tablets daily in divided doses.
The above doses are best taken about 1 hour before meals.
Method of administration:
The route of administration for Ferrous Gluconate 300mg tablets is
oral.
4.3
CONTRAINDICATIONS
Hypersensitivity to the active ingredient ferrous gluconate or to any
of the
excipients listed in section 6.1.
Iron preparations are contra-indicated in patients with
haemochromatosis, iron
storage or absorption diseases such as and haemosiderosis or
haemoglobinuria.
Iron is contraindicated in patients receiving repeated blood
transfusions, or in
patients receiving parenteral iron therapy or to patients with
anaemias not
produced by iron deficiency (some conditions, such as thalassemia may
cause
excess storage of iron).
Alcoholism and hepatitis.
Iron preparations are contraindicated in active peptic ulcer, regional
enteritis
and ulcerative colitis.
Ferrous Gluconate Tablets should not be used in patients with anaemia
not
produced by iron deficiency unless iron deficiency is also present.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE Large doses may have irritant/corrosive effect on gastro-intestinal
mucosa
which can lead to necrosis and pe